Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis.
暂无分享,去创建一个
[1] Ludwig Kappos,et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis , 1999, The Lancet.
[2] A J Thompson,et al. Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. , 1999, Neurology.
[3] M Filippi,et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI , 1999, Neurology.
[4] M Filippi,et al. Interscanner variation in brain MR lesion load measurements in multiple sclerosis using conventional spin-echo, rapid relaxation-enhanced, and fast-FLAIR sequences. , 1999, AJNR. American journal of neuroradiology.
[5] M W Weiner,et al. A serial study of new MS lesions and the white matter from which they arise , 1998, Neurology.
[6] Ludwig Kappos,et al. Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis , 1998, The Lancet.
[7] G. Ebers,et al. Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis , 1998, The Lancet.
[8] P M Matthews,et al. Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging. , 1998, Brain : a journal of neurology.
[9] J. Caillé,et al. Early structural changes in acute MS lesions assessed by serial magnetization transfer studies , 1998, Neurology.
[10] M. Horsfield,et al. A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials. , 1998, Brain : a journal of neurology.
[11] J. Daurès,et al. Unselected brain 0.5-T MR imaging: comparison of lesion detection and characterization with three T2-weighted sequences. , 1998, Radiology.
[12] G J Barker,et al. Serial magnetization transfer imaging to characterize the early evolution of new MS lesions , 1998, Neurology.
[13] M. Filippi,et al. Magnetization transfer ratios of multiple sclerosis lesions with variable durations of enhancement , 1998, Journal of the Neurological Sciences.
[14] D. Arnold,et al. In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging , 1998, Annals of neurology.
[15] M. Rovaris,et al. MRI evolution of new MS lesions enhancing after different doses of gadolinium , 1998, Acta neurologica Scandinavica.
[16] P M Matthews,et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. , 1998, Brain : a journal of neurology.
[17] M Rovaris,et al. A longitudinal brain MRI study comparing the sensitivities of the conventional and a newer approach for detecting active lesions in multiple sclerosis , 1998, Journal of the Neurological Sciences.
[18] H. Adams,et al. Assessing information in T2-weighted MRI scans from secondary progressive MS patients , 1998, Neurology.
[19] G. Barker,et al. Spinal cord atrophy and disability in MS , 1998, Neurology.
[20] G. Barker,et al. Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques , 1998, Journal of neurology, neurosurgery, and psychiatry.
[21] Massimo Filippi,et al. Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis , 1998, Journal of the Neurological Sciences.
[22] M. Horsfield,et al. A one year study of new lesions in multiple sclerosis using monthly gadolinium enhanced MRI: Correlations with changes of T2 and magnetization transfer lesion loads , 1998, Journal of the Neurological Sciences.
[23] M. Filippi,et al. Triple dose of gadolinium-DTPA increases the sensitivity of spinal cord MRI in detecting enhancing lesions in multiple sclerosis , 1998, Journal of the Neurological Sciences.
[24] J K Udupa,et al. Correlation of volumetric magnetization transfer imaging with clinical data in MS , 1998, Neurology.
[25] J K Udupa,et al. Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis. , 1998, AJNR. American journal of neuroradiology.
[26] F. Fera,et al. Randomized trial comparing two different high doses of methylprednisolone in MS A clinical and MRI study , 1998, Neurology.
[27] S. Rombouts,et al. Visual activation patterns in patients with optic neuritis , 1998, Neurology.
[28] M Rovaris,et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis , 1998, Neurology.
[29] C. Wolfson,et al. Multiple sclerosis of the spinal cord: diagnosis and follow-up with contrast-enhanced MR and correlation with clinical activity. , 1998, AJNR. American journal of neuroradiology.
[30] M Filippi,et al. Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis , 1998, Annals of neurology.
[31] C. V. Jensen,et al. Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis , 1998, Neurology.
[32] G. Comi,et al. Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium , 1998, Neurology.
[33] F. Barkhof,et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.
[34] J. K. Udupa,et al. Isolated U-fiber involvement in MS , 1998, Neurology.
[35] Marco Rovaris,et al. The effect of repositioning on brain MRI lesion load assessment in multiple sclerosis: reliability of subjective quality criteria , 1998, Journal of Neurology.
[36] T. Yousry,et al. Common variable immunodeficiency leading to spinal subacute combined degeneration monitored by MRI , 1998, Journal of neurology, neurosurgery, and psychiatry.
[37] M. Sormani,et al. Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis , 1998, Neurology.
[38] J A Frank,et al. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis , 1998, Annals of neurology.
[39] F. Barkhof,et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. , 1998, AJNR. American journal of neuroradiology.
[40] M Rovaris,et al. Intraobserver and interobserver variability in measuring changes in lesion volume on serial brain MR images in multiple sclerosis. , 1998, AJNR. American journal of neuroradiology.
[41] F. Barkhof,et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. , 1998, Brain : a journal of neurology.
[42] A. Thompson,et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. , 1998, Brain : a journal of neurology.
[43] I. Moseley,et al. Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination , 1998, Journal of neurology, neurosurgery, and psychiatry.
[44] F. Barkhof,et al. Correlations between monthly enhanced MRI Lesion rate and changes in T2 Lesion volume in multiple sclerosis , 1998, Annals of neurology.
[45] M. Horsfield,et al. Effect of steroids on Gd‐enhancing lesions before and during recombinant beta interferon la treatment in relapsing remitting multiple sclerosis , 1998, Neurology.
[46] M Filippi,et al. Characteristics of chronic MS lesions in the cerebrum, brainstem, spinal cord, and optic nerve on T1‐‐‐weighted MRI , 1998, Neurology.
[47] G. Comi,et al. Intraobserver and interobserver variability in schemes for estimating volume of brain lesions on MR images in multiple sclerosis. , 1998, AJNR. American journal of neuroradiology.
[48] F. Barkhof,et al. Sagittal MR of multiple sclerosis in the spinal cord: fast versus conventional spin-echo imaging. , 1998, AJNR. American journal of neuroradiology.
[49] R. Tarducci,et al. 1H-MRS in patients with multiple sclerosis undergoing treatment with interferon β-1a: results of a preliminary study , 1998, Journal of neurology, neurosurgery, and psychiatry.
[50] A. Thompson,et al. Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features. , 1998, Brain : a journal of neurology.
[51] A J Thompson,et al. MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences , 1998, Journal of neurology, neurosurgery, and psychiatry.
[52] Jeanelle Sheeder,et al. Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis , 1998 .
[53] J S Wolinsky,et al. Serial proton magnetic resonance spectroscopic imaging, contrast‐enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis , 1998, Annals of neurology.
[54] A. Thompson,et al. Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups , 1998, Journal of neurology, neurosurgery, and psychiatry.
[55] S. Reingold,et al. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. , 1998, Brain : a journal of neurology.
[56] P M Matthews,et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. , 1998, Brain : a journal of neurology.
[57] H. Hartung,et al. Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis. , 1998, Brain : a journal of neurology.
[58] G. Barker,et al. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis , 1997, Journal of neurology, neurosurgery, and psychiatry.
[59] M Rovaris,et al. Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis , 1997, Neurology.
[60] G. Comi,et al. Serial contrast-enhanced MR in patients with multiple sclerosis and varying levels of disability. , 1997, AJNR. American journal of neuroradiology.
[61] A J Thompson,et al. Multiple sclerosis lesion detection in the brain: A comparison of fast fluid-attenuated inversion recovery and conventional T2-weighted dual spin echo , 1997, Neurology.
[62] G J Barker,et al. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. , 1997, Brain : a journal of neurology.
[63] P. Scheltens,et al. MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. , 1997, AJNR. American journal of neuroradiology.
[64] G. Barker,et al. Serial magnetisation transfer ratios in gadolinium-enhancing lesions in multiple sclerosis , 1997, Journal of Neurology.
[65] M. Rovaris,et al. Sensitivity and Reproducibility of Fast‐FLAIR, FSE, and TGSE Sequences for the MRI Assessment of Brain Lesion Load in Multiple Sclerosis: A Preliminary Study , 1997, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[66] L Bozzao,et al. Fast spin-echo and fast fluid-attenuated inversion-recovery versus conventional spin-echo sequences for MR quantification of multiple sclerosis lesions. , 1997, AJNR. American journal of neuroradiology.
[67] A comparison of conventional and fast spin-echo sequences for the measurement of lesion load in multiple sclerosis using a semi-automated contour technique , 1997, Neuroradiology.
[68] A. Thompson,et al. Imaging of the spinal cord and brain in multiple sclerosis: a comparative study between fast flair and fast spin echo , 1997, Journal of Neurology.
[69] J Foong,et al. Executive function in multiple sclerosis. The role of frontal lobe pathology. , 1997, Brain : a journal of neurology.
[70] M. Horsfield,et al. Spinal cord MRI in multiple sclerosis with multicoil arrays: a comparison between fast spin echo and fast FLAIR. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[71] A J Thompson,et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. , 1996, Brain : a journal of neurology.
[72] R I Grossman,et al. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: Estimation of macroscopic and microscopic disease burden , 1996, Magnetic resonance in medicine.
[73] D. Prayer,et al. Spinal cord lesions in patients with multiple sclerosis: comparison of MR pulse sequences. , 1996, AJNR. American journal of neuroradiology.
[74] A. Thompson,et al. Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. , 1996, Brain : a journal of neurology.
[75] W. I. McDonald,et al. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis , 1996, Neurology.
[76] M Filippi,et al. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS , 1996, Neurology.
[77] G. Barker,et al. MRI dynamics of brain and spinal cord in progressive multiple sclerosis. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[78] R. Knobler,et al. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. , 1995, Radiology.
[79] M Filippi,et al. A Magnetization Transfer Imaging Study of Normal-Appearing White Matter in Multiple Sclerosis , 1995, Neurology.
[80] J. Grafman,et al. Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis , 1994, Neurology.
[81] A. Thompson,et al. Spinal cord MRI using multi‐array coils and fast spin echo , 1993, Neurology.
[82] B E Kendall,et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.